Abstract: A battery module includes a battery column, a heat insulation pad and a side plate. The battery column includes a plurality of batteries, and the batteries are arranged in a first direction. The heat insulation pad is disposed between two adjacent batteries in the battery column. The side plate is disposed on a side surface of the battery column and extends in the first direction. At least one heat-resistant region is disposed on the side plate and corresponds to a position of the heat insulation pad. The heat-resistant region is any one of a through hole, a blind hole, and a notch or a combination of two or more of the foregoing communicated with each other. At least a portion of an orthographic projection of the heat insulation pad on the side plate is disposed within the heat-resistant region.

Abstract: Described herein are compositions and methods of forming a dielectric film comprising silicon and carbon onto at least a surface of a substrate, the method comprising introducing into a reactor at least one silacycloalkane precursor selected from the group consisting of compounds represented by the structure of Formula IA and compounds represented by the structure of Formula IB: as defined herein.

Abstract: A composition, and method for using the composition, in the fabrication of an electronic device, and particularly for depositing a film comprising silicon and boron having low dielectric constant (<6.0) and high oxygen ash resistance. The film includes silicon and boron and may be, without limitation, a silicon borocarboxide, a silicon borocarbonitride, a silicon boroxide, or a silicon borocarboxynitride.

Abstract: Processes for depositing silicon-containing films (e.g., silicon, amorphous silicon, silicon oxide, silicon nitride, silicon carbide, silicon oxynitride, silicon carbonitride, doped silicon films, and metal-doped silicon nitride films) are performed using halidosilane precursors. Examples of halidosilane precursor compounds described herein, include, but are not limited to, monochlorodisilane (MCDS), monobromodisilane (MBDS), monoiododisilane (MIDS), monochlorotrisilane (MCTS), and monobromotrisilane (MBTS), monoiodotrisilane (MITS).

Abstract: The disclosure relates a battery technology field, and in particular, relates to a battery pack. The battery pack includes a battery array and a liquid cooling tube. The battery array includes at least two batteries, and the batteries are arranged in a first direction. The liquid cooling tube is disposed on a surface of the battery array and is configured to dissipate heat for the batteries. The liquid cooling tube includes cooling portions, and the cooling portions are portions of an orthographic projection of the liquid cooling tube on the battery array. Orthographic projections of the cooling portions on the battery array are cooling regions. In the battery array, at least one of the batteries is located outside a range of the cooling portions.

Abstract: A power supply system and a control method and control device thereof are provided. The power supply system includes a first power supply device, a heat-dissipation unit, a second power supply device, and a control device. The control device is configured to confirm whether each battery pack in the first power supply device experiences thermal runaway, and control the first power supply device to supply power to the heat-dissipation unit when no battery pack in the first power supply device experiences thermal runaway, so that the heat-dissipation unit dissipates heat from the first power supply device; and control a battery pack not experiencing thermal runaway in the first power supply device and/or the second power supply device to supply power to the heat-dissipation unit when a battery pack in the first power supply device experiences thermal runaway, so that the heat-dissipation unit dissipates heat from the first power supply device.

Abstract: A battery apparatus includes at least two battery units. Each of the battery units includes at least two batteries. A heat insulating pad is disposed between the adjacent two battery units, and at least a pair of the adjacent two batteries belonging to a same battery unit contact each other with largest surfaces of the batteries.

Abstract: A power supply system and a control method and control device thereof are provided. The power supply system includes a first power supply device, a heat-dissipation unit, a second power supply device, and a control device. The control device is configured to confirm whether each battery pack in the first power supply device experiences thermal runaway, and control the first power supply device to supply power to the heat-dissipation unit when no battery pack in the first power supply device experiences thermal runaway, so that the heat-dissipation unit dissipates heat from the first power supply device; and control a battery pack not experiencing thermal runaway in the first power supply device and/or the second power supply device to supply power to the heat-dissipation unit when a battery pack in the first power supply device experiences thermal runaway, so that the heat-dissipation unit dissipates heat from the first power supply device.

Abstract: A battery pack includes a battery column and a liquid cooling tube. The battery column includes at least two batteries, and the batteries are arranged in a first direction. The liquid cooling tube is disposed on a surface of the battery column and is configured to dissipate heat for the batteries. The liquid cooling tube includes cooling portions, and the cooling portions are portions having orthographic projections on the battery column. The orthographic projections of the cooling portions on the battery column are cooling regions. The cooling portions extend in a second direction, and the second direction is not parallel to the first direction.

Abstract: The disclosure relates a battery technology field, and in particular, relates to a battery pack. The battery pack includes a battery array and a liquid cooling tube. The battery array includes at least two batteries, and the batteries are arranged in a first direction. The liquid cooling tube is disposed on a surface of the battery array and is configured to dissipate heat for the batteries. The liquid cooling tube includes cooling portions, and the cooling portions are portions of an orthographic projection of the liquid cooling tube on the battery array. Orthographic projections of the cooling portions on the battery array are cooling regions. In the battery array, at least one of the batteries is located outside a range of the cooling portions.

Abstract: A battery module includes a battery column, a heat insulation pad and a side plate. The battery column includes a plurality of batteries, and the batteries are arranged in a first direction. The heat insulation pad is disposed between two adjacent batteries in the battery column. The side plate is disposed on a side surface of the battery column and extends in the first direction. At least one heat-resistant region is disposed on the side plate and corresponds to a position of the heat insulation pad. The heat-resistant region is any one of a through hole, a blind hole, and a notch or a combination of two or more of the foregoing communicated with each other. At least a portion of an orthographic projection of the heat insulation pad on the side plate is disposed within the heat-resistant region.

Abstract: A battery includes a housing, a first terminal, a second terminal and a fuse structure provided between the first terminal and the housing. The fuse structure is arranged to control the housing to be insulated from the first terminal when the current between the housing and the first terminal is greater than the preset fuse point, and the electrical connection between the housing and the first terminal is disconnected, so as to cut off the conductive path between the first terminal and the housing.

Abstract: A sodium alginate crosslinked slow-released moxifloxacin microsphere, the preparation method of the microsphere, a vascular target embolus containing the microsphere and the use of the microsphere in preparing the vascular target embolus. The microsphere contains moxifloxacin, a drug carrier, a adsorbent, a reinforcing agent and a solidifying agent, wherein the drug carrier is sodium alginate, the adsorbent is albumin prepared from human plasma or bovine serum albumin, the reinforcing agent is gelatin or hyaluronic acid, and the solidifying agent is a divalent metal cation chosen from calcium salt or barium salt.

Abstract: A sodium alginate crosslinked slow-released moxifloxacin microsphere, the preparation method of the microsphere, a vascular target embolus containing the microsphere and the use of the microsphere in preparing the vascular target embolus. The microsphere contains moxifloxacin, a drug carrier, a adsorbent, a reinforcing agent and a solidifying agent, wherein the drug carrier is sodium alginate, the adsorbent is albumin prepared from human plasma or bovine serum albumin, the reinforcing agent is gelatin or hyaluronic acid, and the solidifying agent is a divalent metal cation chosen from calcium salt or barium salt.

Abstract: A targeted sustained-release microsphere vascular embolizing agent, the production method and the use thereof are disclosed. The microsphere comprises sodium alginate as the carrier and sorafenib as the targeted anti-tumor medicine and sorafenib is encapsulated by sodium alginate. The weight ratio of sorafenib to sodium alginate is 1:1˜1:30. The microspheres are used for manufacturing medicament for the treatment of solid tumors with advantages including high medicine concentration in the target regions with reduced systemic dosage and toxic and side effects.

Abstract: The present invention relates to a kind of sodium alginate microsphere vascular embolus containing gynecological drug and its preparation. The preparation of it consists of the following steps: preparing the solution of gynecological drug, sodium alginate and dilvalent metal cations such as BaCl2, Mg Cl2 or CaCl2 etc. by order; mixing the gynecological drug solution and sodium alginate solution, and then mixing them with the curing solution of BaCl2 or CaCl2 and the like. Then the obtained is the sodium alginate microshere vascular embolus containing gynecological drug. The carrier materials of the vascular embolus according to the invention are natural extracts and have good biocompatibility and re biodegradable; the side effect of the pharmaceutic loaded by them is minimal, and it is especially suitable for myometrial gland and hysteromyoma.

Abstract: Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation. The preparation of it consists of the following steps: preparing the solution of paclitaxel, sodium alginate and dilvalent metal cations such as BaCl2 or CaCl2 etc. by order; mixing the paclitaxel solution and sodium alginate solution, and then mixing them with the curing solution of BaCl2 or CaCl2 and the like. Then the obtained is the sodium alginate microshere vascular embolus containing paclitaxel. The carrier materials of the vascular embolus according to the invention are natural extracts and have good biocompatibility and re biodegradable; the side effect of the pharmaceutic loaded by them is minimal, and it is therefore suitable for the vascular embolism and chemotherapy against the tumor.

Abstract: Microencapsulated medicine of ox adrenal medulla pheochromocyte (BBC) for treating pain is prepared through the following steps: 1. suspending BBC in solution of sodium alginate; 2. dispersing the suspension in solution of calcium chloride to form calcium alginate bead deposit; 3. mixing the deposit with solution of polylysine to form a coating and depositing; 4. mixing the deposit with sodium alginate to form a coating; 5. displacing the calcium ions in deposit with sodium citrate for microencapsulating BBC; 6. transferring the microencapsulated BBC into culture liquid for storage. The medicine can release analgesic substance for several months after it be implanted into human body.

Abstract: Microencapsulated medicine of ox adrenal medulla pheochromocyte (BBC) for treating pain is prepared through the following steps: 1. suspending BBC in solution of sodium alginate; 2. dispersing the suspension in solution of calcium chloride to form calcium alginate bead deposit; 3. mixing the deposit with solution of polylysine to form a coating and depositing; 4. mixing the deposit with sodium alginate to form a coating; 5. displacing the calcium ions in deposit with sodium citrate for microencapsulating BBC; 6. transferring the microencapsulated BBC into culture liquid for storage. The medicine can release analgesic substance for several months after it be implanted into human body.